A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age

NCT00946101 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

326

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal]
BIOLOGICAL: Placebo

Sponsor

MedImmune LLC

Collaborators

[object Object]